Author Topic: Beta interferon drugs for MS seem to prolong life for over 30% of persons w/RRMS  (Read 17 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8218
  • MS diagnosed 1980
  • Location: Pacific Northwest
This study is concerned with all of the interferon drugs in use for MS (interferon beta 1a and interferon beta 1b)--like Betaseron, Avonex, Rebif --"Common treatment for multiple sclerosis may prolong life" from the UBC News (March 18, 2019).


https://news.ubc.ca/2019/03/18/common-treatment-for-multiple-sclerosis-may-prolong-life/


The study subjects were people with relapsing-onset MS--they either had RRMS or had SPMS that had had a relapsing onset.


The original article in Brain (March 18, 2019)--"Multiple sclerosis: Effect of beta interferon treatment on survival":


https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awz055/5382233
« Last Edit: April 26, 2019, 03:50:05 pm by agate »
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
59 Views
Last post November 24, 2016, 08:04:14 am
by agate
0 Replies
47 Views
Last post June 27, 2017, 03:52:35 pm
by agate
0 Replies
90 Views
Last post August 01, 2017, 08:28:52 am
by agate
0 Replies
30 Views
Last post December 29, 2018, 04:21:30 pm
by agate
0 Replies
16 Views
Last post March 19, 2019, 04:23:50 pm
by agate